PL
PL · PL · PL-100316148
Simulect
ATC L04AC02
Last synced from URPL (Poland) on
Identification
ManufacturerNovartis Europharm Limited
CountryPL (PL)
ATC codeL04AC02
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909990428113
- gtin07613421176105
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań lub infuzji",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909990428113 ¦ Rpz ¦ EU/1/98/084/001 ¦ 91444\n1 fiol. 20 mg proszku ¦ 1 amp. 5 ml rozp.\n07613421176105 ¦ Rpz ¦ EU/1/98/084/004 ¦ 151913\n1 fiol. 20 mg proszku",
"substance": "Basiliximabum 20 mg",
"common_name": "Basiliximabum",
"pl_product_id": "100316148",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L04AC02.
- ISSimulectNovartis Europharm Limited*
- 🇺🇸SimulectNovartis Pharmaceuticals Corporation
- ISSimulectNovartis Europharm Limited*
- ISSimulectNovartis Europharm Limited*
- ISSimulectNovartis Europharm Limited*
- PLSimulectNovartis Europharm Limited
- DKSimulectNovartis Europharm Limited
- 🇺🇸SimulectNovartis Pharmaceuticals Corporation
Access this data programmatically
Query Simulect and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.